212622-34-9Relevant articles and documents
PYRIDAZINONE GLUCOKINASE ACTIVATORS
-
Page/Page column 48, (2009/10/30)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
Retro-ene reaction. V. Functionalization of 4,5-dihalopyridazin-6-ones using 1-hydroxymethyl-4,5-dihalopyridazin-6-ones as 1-O, 3-N, 5-O ene- adducts
Chung, Hyun-A.,Kang, Young-Jin,Chung, Joo-Wha,Cho, Su-Dong,Yoon, Yong-Jin
, p. 277 - 281 (2007/10/03)
Functionalization of 1-hydroxymethyl-4,5-dihalopyridazin-6-ones via a retro-ene reaction with some nucleophiles gave regioselectively only 5-halo- 4-substitutedpyridazin-6-ones.
Functionalization of 4,5-Dihalopyridazin-6-ones Using 1-(1,1-Dibromo-2-oxopropyl) Derivatives
Kang, Young-Jin,Chung, Hyun-A,Kweon, Deok-Heon,Cho, Su-Dong,Lee, Sang-Gyeong,Kim, Sung-Kyu,Yoon, Yong-Jin
, p. 595 - 600 (2007/10/03)
Functionalization of 4,5-dihalopyridazin-6-ones using 1-(1,1-dibromo-2-oxopropyl)-4,5-dihalopyridazin-6-ones with some nucleophiles gave regioselectively only 5-halo-4-substituted-pyridazin-6-ones.